Is Monte Rosa Therapeutics, Inc. GLUE stock halal to invest in?

No, as of August 2026, Monte Rosa Therapeutics, Inc. stock (GLUE) is not currently classified as a Shariah compliant stock. This verdict follows the screening methodology of AAOIFI (the Accounting and Auditing Organization for Islamic Financial Institutions), whose Shariah Standard No. 21 is the leading global benchmark for screening halal stocks. To qualify as halal under this standard, a company must keep non-permissible income below 5% of total revenue, keep both interest-bearing investments and interest-bearing debt below 30% of market capitalisation, and have no impermissible preference share structure. Monte Rosa Therapeutics, Inc. currently does not meet the threshold for the non-permissible income and interest-bearing investments screens. Because screenings are refreshed monthly as new financial reports are published, a non-compliant stock can regain compliant status if its financial structure changes. You can track the latest status of Monte Rosa Therapeutics, Inc. and discover Shariah compliant alternatives among the halal stocks in the Tabadulat app.

How often is Monte Rosa Therapeutics, Inc. GLUE reviewed for Shariah compliance?

Tabadulat reviews Monte Rosa Therapeutics, Inc. GLUE for Shariah compliance every month. Each review applies the AAOIFI Shariah Standard No. 21 methodology, screening the company's business activities, non-permissible income, interest-bearing investments, interest-bearing debt, and preference shares, against the company's latest available financial data. The process operates under the direct supervision of Tabadulat's dedicated Shariah Supervisory Board of Islamic finance scholars. Because compliance depends on financial ratios that move with market capitalisation and reported results, a stock's status can change from one review to the next. Monthly screening ensures the status shown for Monte Rosa Therapeutics, Inc. reflects current financial data rather than an outdated assessment, and Tabadulat app users are notified if a holding in their portfolio becomes non-compliant.

Does Monte Rosa Therapeutics, Inc. GLUE pass the AAOIFI Non Permissible Income criteria?

No, as of August 2026, Monte Rosa Therapeutics, Inc. stock (GLUE) does not pass the AAOIFI non-permissible income screen. Under AAOIFI Shariah Standard No. 21, income from impermissible sources (such as interest or riba, conventional financial services, alcohol, gambling, or tobacco) must remain below 5% of a company's total revenue. Monte Rosa Therapeutics, Inc.'s income from non-permissible sources currently exceeds this 5% ceiling, which makes the stock non-compliant on this criterion regardless of how it performs on the other screens. The screen is reassessed monthly, so the status can change when the company releases new financial statements.

Does Monte Rosa Therapeutics, Inc. GLUE pass the AAOIFI Interest Bearing Investments criteria?

No, as of August 2026, Monte Rosa Therapeutics, Inc. stock (GLUE) does not pass the AAOIFI interest-bearing investments screen. Under AAOIFI Shariah Standard No. 21, the cash a company places in interest-earning instruments (such as conventional deposits, bonds, treasury bills and money-market funds) must remain below 30% of its market capitalisation. Monte Rosa Therapeutics, Inc.'s interest-bearing investments currently exceed this 30% limit, meaning too large a share of the company's value derives from riba-based instruments for the stock to qualify as halal on this criterion. The ratio moves with both the balance sheet and the share price, and is reassessed monthly.

Does Monte Rosa Therapeutics, Inc. GLUE pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of August 2026, Monte Rosa Therapeutics, Inc. stock (GLUE) passes the AAOIFI interest-bearing debt screen. Under AAOIFI Shariah Standard No. 21, a company's borrowings that accrue interest (conventional bank loans, bonds and similar riba-based financing) must remain below 30% of its market capitalisation. This cap limits shareholders' exposure to interest-based leverage. Monte Rosa Therapeutics, Inc.'s interest-bearing debt is currently within the 30% threshold. Because market capitalisation changes daily, a company's debt ratio can drift toward or away from the limit even without new borrowing, which is why this screen is reassessed every month.

What is the dividend purification factor for Monte Rosa Therapeutics, Inc. GLUE stock?

Monte Rosa Therapeutics, Inc. (GLUE) is currently classified as not Shariah compliant, so no dividend purification factor applies, because purification factors are calculated only for stocks that pass the AAOIFI screens. Purification (tazkiyah) is the practice of donating to charity the small portion of dividend income that stems from incidental non-permissible sources, such as interest earned on a compliant company's cash deposits. For non-compliant stocks the issue is not purification but eligibility: under AAOIFI Shariah Standard No. 21 the stock does not currently qualify as a halal investment. If Monte Rosa Therapeutics, Inc. returns to compliance in a future monthly screening, its purification factor will be published alongside its updated status in the Tabadulat app.

Does Monte Rosa Therapeutics, Inc. GLUE pass the AAOIFI Preference Share screen?

Yes, as of August 2026, Monte Rosa Therapeutics, Inc. stock (GLUE) passes the AAOIFI preference share screen. AAOIFI Shariah Standard No. 21 prohibits investing in preference shares because they grant holders guaranteed or priority rights to dividends and capital ahead of ordinary shareholders, a structure that conflicts with the Shariah principle that investors should share profit and loss in proportion to their ownership. Monte Rosa Therapeutics, Inc. has no impermissible preference share structure affecting its ordinary shares, so the stock is compliant on this criterion. Like all AAOIFI screens, this is verified in each monthly review.

English

العربية

Invest Halal, Anytime, Anywhere

Download the Tabadulat app and start building your Shariah-compliant portfolio in minutes.

Monte Rosa Therapeutics, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

GLUE

About

Monte Rosa Therapeutics, Inc.

GLUE

Monte Rosa Therapeutics Inc. is a biotechnology company that focuses on developing innovative therapies through the targeted degradation of proteins. Specializing in a cutting-edge approach known as "molecular glue," the company seeks to identify and design small molecules capable of selectively degrading disease-relevant proteins. This approach has wide-ranging potential applications, including oncology, where Monte Rosa Therapeutics aims to address unmet medical needs by dismantling proteins that drive cancer progression. Headquartered in Cambridge, Massachusetts, the company leverages advanced insights from chemical biology, structural biology, and computational chemistry. Monte Rosa Therapeutics plays a pivotal role in the biotechnology sector by offering a new paradigm for drug discovery, exploring the vast untapped space of disease-causing proteins that are traditionally considered "undruggable." As the demand for innovative cancer treatments and other therapies continues to grow, Monte Rosa Therapeutics positions itself as a leader in the development of next-generation therapeutics, contributing to the broader landscape of health and biotechnology advancements.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

147

Website:

https://www.monterosatx.com

GLUE

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Open your account.

Create your Tabadulat account in minutes: enter your details, complete identity verification, and add funds by secure transfer in multiple currencies. You're ready to start investing in halal stocks the same day.

Trade Now

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Monte Rosa Therapeutics, Inc.

About

Monte Rosa Therapeutics, Inc.

GLUE

Frequently asked questions

Is Monte Rosa Therapeutics, Inc. GLUE stock halal to invest in?

How often is Monte Rosa Therapeutics, Inc. GLUE reviewed for Shariah compliance?

Does Monte Rosa Therapeutics, Inc. GLUE pass the AAOIFI Non Permissible Income criteria?

Does Monte Rosa Therapeutics, Inc. GLUE pass the AAOIFI Interest Bearing Investments criteria?

Does Monte Rosa Therapeutics, Inc. GLUE pass the AAOIFI Interest Bearing Debt criteria?

What is the dividend purification factor for Monte Rosa Therapeutics, Inc. GLUE stock?

Does Monte Rosa Therapeutics, Inc. GLUE pass the AAOIFI Preference Share screen?

Can I buy Monte Rosa Therapeutics (GLUE) stock on Tabadulat?

Open your account.

Deposit.

Screen.